Am J Nurs

1. 
   News Brief: A quarter of U.S. women are not up to date on cervical cancer screening.
   Am J Nurs. 2024;124:11.
   

   >> Share

   
   

   
   Am J Obstet Gynecol

2. JORGENSEN KA, Agusti N, Wu CF, Kanbergs A, et al
   Fertility-sparing surgery versus standard surgery for early-stage cervical cancer: difference in 5-year life expectancy by tumor size.
   Am J Obstet Gynecol. 2024 Feb 14:S0002-9378(24)00084.
   

   >> Share

   
   

   
   Am J Pathol

3. MASUDA M, Iida K, Iwabuchi S, Tanaka M, et al
   Clonal Origin and Lineage Ambiguity in Mixed Neuroendocrine Carcinoma of the Uterine Cervix.
   Am J Pathol. 2024;194:415-429.
   

   >> Share

   
   

   
   Am J Prev Med

4. PARKER SL, Amboree TL, Bulsara S, Daheri M, et al
   Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System.
   Am J Prev Med. 2024;66:540-547.
   

   >> Share

   
   

   
   Ann Diagn Pathol

5. KUZUCULAR E, Ozden F, Muezzinoglu B
   Comparison of liquid-based cytology and cell blocks prepared from cell remnants for diagnosis of cervical pathology.
   Ann Diagn Pathol. 2024;69:152265.
   

   >> Share

   
   

   
   Appl Biochem Biotechnol

6. GIRIJA NS, Neethi B, Sakthimanipriya L, Sinekha MA, et al
   In-Vitro Cytotoxic, Antiproliferative and Apoptotic Activity of Siddha Formulation Nandhi Mezhugu (NM) Against Hela Cell Line.
   Appl Biochem Biotechnol. 2024;196:1612-1622.
   

   >> Share

   
   

   
   Appl Microbiol Biotechnol

7. ZHOU X, Wang Y, Bao M, Chu Y, et al
   Advanced detection of cervical cancer biomarkers using engineered filamentous phage nanofibers.
   Appl Microbiol Biotechnol. 2024;108:221.
   

   >> Share

   
   

   
   Biology (Basel)

8. ROSENDO-CHALMA P, Antonio-Vejar V, Ortiz Tejedor JG, Ortiz Segarra J, et al
   The Hallmarks of Cervical Cancer: Molecular Mechanisms Induced by Human Papillomavirus.
   Biology (Basel). 2024;13:77.
   

   >> Share

   
   

   
   Biomarkers

9. KAUR JAWANDA I, Soni T, Kumari S, Prabha V, et al
   Deciphering the potential of proteomic-based biomarkers in women's reproductive diseases: empowering precision medicine in gynecology.
   Biomarkers. 2024;29:7-17.
   

   >> Share

   
   

   
   BMC Cancer

10. NAKIGOZI H, Ndejjo R, Bazeyo W, Nabaggala A, et al
    Prevalence of genital high-risk human papillomavirus infections and associated factors among women living with human immunodeficiency virus in Uganda.
    BMC Cancer. 2024;24:243.
    

    >> Share

    
    
11. CORREDOR C, Pineros M, Wiesner C, de Vries E, et al
    Using administrative registries as a source for population-based cancer incidence and mortality.
    BMC Cancer. 2024;24:232.
    

    >> Share

    
    

    
    BMC Genomics

12. WANG Z, Liu C, Liu W, Lv X, et al
    Long-read sequencing reveals the structural complexity of genomic integration of HPV DNA in cervical cancer cell lines.
    BMC Genomics. 2024;25:198.
    

    >> Share

    
    

    
    BMC Infect Dis

13. LU Y, Wu Q, Wang L, Ji L, et al
    Chlamydia trachomatis enhances HPV persistence through immune modulation.
    BMC Infect Dis. 2024;24:229.
    

    >> Share

    
    

    
    BMC Public Health

14. MANTULA F, Toefy Y, Sewram V
    Barriers to cervical cancer screening in Africa: a systematic review.
    BMC Public Health. 2024;24:525.
    

    >> Share

    
    
15. OKO-OBOH GA, Auvinen A, Obaseki DE, Pitkaniemi J, et al
    Improving cancer incidence evaluation through local government area matching: a study of the Edo-Benin cancer registry in Nigeria.
    BMC Public Health. 2024;24:514.
    

    >> Share

    
    

    
    BMC Womens Health

16. EKAWATI FM, Listiani P, Idaiani S, Thobari JA, et al
    Cervical cancer screening program in Indonesia: is it time for HPV-DNA tests? Results of a qualitative study exploring the stakeholders' perspectives.
    BMC Womens Health. 2024;24:125.
    

    >> Share

    
    
17. SUKRONG M, Prapaisilp P, Juntamongkol T, Siranart N, et al
    Knowledge regarding human papillomavirus and cervical cancer prevention among medical students from Chulalongkorn University in Thailand.
    BMC Womens Health. 2024;24:129.
    

    >> Share

    
    

    
    Br J Cancer

18. DOWNHAM L, Jaafar I, Rol ML, Nyawira Nyaga V, et al
    Accuracy of HPV E6/E7 oncoprotein tests to detect high-grade cervical lesions: a systematic literature review and meta-analysis.
    Br J Cancer. 2023 Nov 16. doi: 10.1038/s41416-023-02490.
    

    >> Share

    
    

    
    Cancer Biol Ther

19. WANG YY, Ye LH, Zhao AQ, Gao WR, et al
    M6A modification regulates tumor suppressor DIRAS1 expression in cervical cancer cells.
    Cancer Biol Ther. 2024;25:2306674.
    

    >> Share

    
    

    
    Cancer Cell Int

20. CHEN X, Dong X, Li H, Wu T, et al
    RNA-binding proteins signature is a favorable biomarker of prognosis, immunotherapy and chemotherapy response for cervical cancer.
    Cancer Cell Int. 2024;24:80.
    

    >> Share

    
    
21. LUO L, Wang M, Li X, Luo C, et al
    Correction: A novel mechanism by which ACTA2-AS1 promotes cervical cancer progression: acting as a ceRNA of miR-143-3p to regulate SMAD3 expression.
    Cancer Cell Int. 2024;24:76.
    

    >> Share

    
    

    
    Chin Herb Med

22. CHEN Y, Chen S, Chen K, Ji L, et al
    Magnolol and 5-fluorouracil synergy inhibition of metastasis of cervical cancer cells by targeting PI3K/AKT/mTOR and EMT pathways.
    Chin Herb Med. 2023;16:94-105.
    

    >> Share

    
    

    
    Clin Cancer Res

23. LOU H, Cai H, Huang X, Li G, et al
    Cadonilimab combined with chemotherapy with or without bevacizumab as first-line treatment in recurrent or metastatic cervical cancer (COMPASSION-13): a phase 2 study.
    Clin Cancer Res. 2024 Feb 19. doi: 10.1158/1078-0432.CCR-23-3162.
    

    >> Share

    
    

    
    Cureus

24. G SN, Sssn R, Chaturvedula L, Adole P, et al
    Deoxyribose Nucleic Acid Damage and Its Association With Plasma Malondialdehyde Levels Among Patients With Cervical Cancer: A Case-Control Study.
    Cureus. 2024;16:e52600.
    

    >> Share

    
    
25. DURA MC, Akturk H, Aslan O, Yildiz S, et al
    Human Papillomavirus Infection (HPV) Prevalence in the Black Sea Region of Turkey: Primary HPV Screening for Cervical Cancer.
    Cureus. 2024;16:e52615.
    

    >> Share

    
    

    
    Curr Med Imaging

26. GAO F, Qian T, Sun M, Lu Y, et al
    MRI Plain Scan: A Tool in the Management of Cervical Cancer during Pregnancy.
    Curr Med Imaging. 2024;20:1-8.
    

    >> Share

    
    

    
    Data Brief

27. YADAV R, Chauhan MB, Yadav C, Ranga S, et al
    Awareness data on cervical cancer among females of rural and urban areas of Haryana, India.
    Data Brief. 2024;53:110168.
    

    >> Share

    
    

    
    Ethiop J Health Sci

28. AKINNIBOSUN O, Abakpa OG, Ujoh AJ, Oche DA, et al
    Knowledge, Attitudes and Practices among Women of Reproductive Age on Human Papillomavirus Infection, Cervical Cancer and Vaccination in Otukpo, Nigeria.
    Ethiop J Health Sci. 2024;34:15-26.
    

    >> Share

    
    

    
    Eur J Cancer

29. TANAKA LF, Schoffer O, Schriefer D, Schauberger G, et al
    An audit of 1632 routinely collected cervical cancer screening smears from 398 women in Germany: Results from the TeQaZ Study.
    Eur J Cancer. 2024;201:113915.
    

    >> Share

    
    

    
    Expert Opin Biol Ther

30. GREENMAN M, McNamara B, Mutlu L, Santin AD, et al
    Targeting cervical cancer with anti-PD-1 antibodies: what's new?
    Expert Opin Biol Ther. 2024 Feb 23. doi: 10.1080/14712598.2024.2323596.
    

    >> Share

    
    

    
    Fam Community Health

31. BAEKER BISPO JA, Goo I, Ashad-Bishop K, Kobetz E, et al
    Does Neighborhood Social Cohesion Influence Participation in Routine Cancer Screening? Findings From a Representative Sample of Adults in South Florida.
    Fam Community Health. 2024;47:130-140.
    

    >> Share

    
    

    
    Front Cardiovasc Med

32. GE J, Weng C, Zhao J, Yuan D, et al
    Upper extremity phlegmasia cerulea dolens complicating supra vena cava embolism in a cervical cancer patient: case report.
    Front Cardiovasc Med. 2024;11:1351358.
    

    >> Share

    
    

    
    Front Med (Lausanne)

33. WU F, Zhang R, Li F, Qin X, et al
    Radiomics analysis based on multiparametric magnetic resonance imaging for differentiating early stage of cervical cancer.
    Front Med (Lausanne). 2024;11:1336640.
    

    >> Share

    
    

    
    Front Microbiol

34. FONG AMARIS WM, de Assumpcao PP, Valadares LJ, Moreira FC, et al
    Microbiota changes: the unseen players in cervical cancer progression.
    Front Microbiol. 2024;15:1352778.
    

    >> Share

    
    

    
    Front Public Health

35. CARMACK C, Roncancio A, Coleman TM, McKay S, et al
    Concept mapping sociocultural aspects of cervical cancer prevention among African American women.
    Front Public Health. 2024;11:1311286.
    

    >> Share

    
    

    
    Gynecol Oncol

36. NASIOUDIS D, Gysler S, Latif N, Cory L, et al
    Molecular landscape of ERBB2/HER2 gene amplification among patients with gynecologic malignancies; clinical implications and future directions.
    Gynecol Oncol. 2023;180:1-5.
    

    >> Share

    
    
37. ROOF KA, Wichmann HK, Carlton LJ, Nguyen ML, et al
    Factors associated with loss to follow up after abnormal cervical cancer screening in pregnancy.
    Gynecol Oncol. 2024;185:46-50.
    

    >> Share

    
    

    
    Gynecol Oncol Rep

38. SHAFFI AF, Odongo EB, Itsura PM, Tonui PK, et al
    Cervical cancer management in a low resource setting: A 10-year review in a tertiary care hospital in Kenya.
    Gynecol Oncol Rep. 2024;51:101331.
    

    >> Share

    
    

    
    Hum Vaccin Immunother

39. STEFANOS R, Lewis RM, Querec TD, Gargano JW, et al
    High impact of quadrivalent human papillomavirus vaccine across racial/ethnic groups: National Health and Nutrition Examination Survey, 2003-2006 and 2015-2018.
    Hum Vaccin Immunother. 2024;20:2308378.
    

    >> Share

    
    

    
    Int J Gen Med

40. MITOMA T, Maki J, Ooba H, Ogawa C, et al
    Association of Regular Cervical Cancer Screening with Socioeconomic, COVID-19 Infection and Vaccine Status Among Japanese Population: Cohort Observational Study.
    Int J Gen Med. 2024;17:541-551.
    

    >> Share

    
    

    
    Int J Gynecol Cancer

41. BIZZARRI N, Obermair A, Hsu HC, Chacon E, et al
    Consensus on surgical technique for sentinel lymph node dissection in cervical cancer.
    Int J Gynecol Cancer. 2024 Feb 20:ijgc-2023-005151.
    

    >> Share

    
    

    
    Int J Surg

42. ZHANG J, Qiu H, Qing Y, Hu Y, et al
    A commentary on "Local excision as a viable alternative to c-stage cervical cancer in women of reproductive age: a population-based cohort study".
    Int J Surg. 2024 Feb 21. doi: 10.1097/JS9.0000000000001218.
    

    >> Share

    
    

    
    Int Wound J

43. HAMID HA, Lin X, Qin YK, Akim AM, et al
    Best practices for managing malodorous and infected wounds in advanced cervical cancer.
    Int Wound J. 2024;21:e14574.
    

    >> Share

    
    

    
    J Cancer Res Clin Oncol

44. GUO S, Chen P, Yang Y, Wei W, et al
    Tumor-to-stroma cd8(+) t cells ratio combined with cancer-associated fibroblasts: an innovative approach to predicting lymph node metastases of cervical cancer.
    J Cancer Res Clin Oncol. 2024;150:93.
    

    >> Share

    
    

    
    J Cancer Res Ther

45. SOOKAROMDEE P, Wiwanitkit V
    Coverage rate of cervical cytology and HPV DNA test for cervix cancer screening: Reappraisal on impact of COVID-19 outbreak.
    J Cancer Res Ther. 2023;19.
    

    >> Share

    
    
46. AKRAM M, Khazir M, Khan M, Afrose R, et al
    Age-wise cancer incidence in western Uttar Pradesh in India: An observational study.
    J Cancer Res Ther. 2023;19.
    

    >> Share

    
    
47. PAUL A, Dutta P, Basu K
    Assessment and clinicopathological correlation of p16 expression in cervical squamous cell carcinoma of Indian population: Diagnostic implications.
    J Cancer Res Ther. 2023;19:2012-2017.
    

    >> Share

    
    
48. PURI I, Sharma R, Dewan D, Angurana S, et al
    Sexual function status after adjuvant radiation including vaginal cuff brachytherapy in survivors of cancer cervix.
    J Cancer Res Ther. 2023;19:1721-1724.
    

    >> Share

    
    
49. AZAK C, Kavak G, Ertan F, Alioglu F, et al
    The effect of lower urinary tract substructure doses on side effects of cervical cancer image-guided adaptive brachytherapy.
    J Cancer Res Ther. 2023;19:1825-1830.
    

    >> Share

    
    
50. DATKHILE KD, Patil SR, Patil MN, Durgawale PP, et al
    Genetic polymorphisms of CYP1A, CYP1B, CYP2C and risk of cervical cancer among rural population of Maharashtra: Findings from a hospital-based case-control study.
    J Cancer Res Ther. 2023;19:1925-1930.
    

    >> Share

    
    

    
    J Gynecol Oncol

51. YOO JG, Lee SJ, Nam EJ, No JH, et al
    Clinical practice guidelines for cervical cancer: the Korean Society of Gynecologic Oncology guidelines.
    J Gynecol Oncol. 2024 Feb 13. doi: 10.3802/jgo.2024.
    

    >> Share

    
    

    
    J Hematop

52. MINGOLA P, Alshomrani A, Greiner T
    Anaplastic large cell lymphoma presenting as a mass in the uterine cervix: a case report.
    J Hematop. 2024;17:23-26.
    

    >> Share

    
    

    
    J Med Screen

53. FOGH JORGENSEN S, Kellen E, Haelens A, Herck KV, et al
    How follow-up rates in cervical cancer screening depend on organizational factors: A comparison of two population-based organized screening programmes.
    J Med Screen. 2024 Feb 21:9691413241231440. doi: 10.1177/09691413241231440.
    

    >> Share

    
    
54. YUILL S, Egger S, Smith MA, Velentzis L, et al
    Participation in the national cervical screening programme among women from New South Wales, Australia, by place of birth and time since immigration: A data linkage analysis using the 45 and up study.
    J Med Screen. 2024;31:35-45.
    

    >> Share

    
    

    
    J Med Virol

55. PRETI M, Boldorini R, Gallio N, Cavagnetto C, et al
    Human papillomavirus genotyping in high-grade vaginal intraepithelial neoplasia: A multicentric Italian study.
    J Med Virol. 2024;96:e29474.
    

    >> Share

    
    

    
    J Nutr

56. PEITZ JG, Adebamowo CA, Adebamowo SN
    Association between Serum Folate and Vaginal High-Risk Human Papillomavirus Infections in United States Women.
    J Nutr. 2024;154:583-589.
    

    >> Share

    
    

    
    J Robot Surg

57. MICHA JP, Rettenmaier MA, Bohart RD, Goldstein BH, et al
    Current analysis of the survival implications for minimally invasive surgery in the treatment of early-stage cervix cancer.
    J Robot Surg. 2024;18:80.
    

    >> Share

    
    

    
    JCO Glob Oncol

58. NDARUKWA S, Flores JA, Rosenblatt E, Berger D, et al
    Brachytherapy Workflow Practices: Analysis of Different Workflow Scenarios in Patients With Cervical Cancer and Impact on IGBT Implementation-An IAEA Study.
    JCO Glob Oncol. 2024;10:e2300336.
    

    >> Share

    
    

    
    Jpn J Clin Oncol

59. 
    Correction to: Quality of life but not cachexia definitions are associated with overall survival in women with cervical cancer: a STROBE-compliant cohort study.
    Jpn J Clin Oncol. 2024 Feb 15:hyae023. doi: 10.1093.
    

    >> Share

    
    

    
    Lancet Glob Health

60. FOKOM-DEFO V, Dille I, Fokom-Domgue J
    Single dose HPV vaccine in achieving global cervical cancer elimination.
    Lancet Glob Health. 2024;12:e360-e361.
    

    >> Share

    
    

    
    Lasers Med Sci

61. CAO Y, Xiong J, Du Y, Tang Y, et al
    Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers.
    Lasers Med Sci. 2024;39:68.
    

    >> Share

    
    

    
    Mol Oncol

62. ZHENG H, Liu M, Shi S, Huang H, et al
    MAP4K4 and WT1 mediate SOX6-induced cellular senescence by synergistically activating the ATF2-TGFbeta2-Smad2/3 signaling pathway in cervical cancer.
    Mol Oncol. 2024 Feb 21. doi: 10.1002/1878-0261.13613.
    

    >> Share

    
    

    
    N Z Med J

63. INGAMELLS S, Bell R, Nip J, Innes C, et al
    Perceived barriers to self-collected HPV testing for cervical cancer screening, and knowledge of HPV: a survey of primary healthcare smear-takers across Aotearoa New Zealand.
    N Z Med J. 2024;137:57-76.
    

    >> Share

    
    

    
    Oncol Lett

64. ZHANG H, Zhang R, Zhang G, Liu W, et al
    [Retracted] Clinical significance of miR?1298 in cervical cancer and its biological function in vitro.
    Oncol Lett. 2024;27:150.
    

    >> Share

    
    

    
    PLoS One

65. VARON ML, Geng Y, Fellman BM, Troisi C, et al
    Interventions to increase follow-up of abnormal cervical cancer screening results: A systematic literature review and meta-analysis.
    PLoS One. 2024;19:e0291931.
    

    >> Share

    
    

    
    Public Health

66. OLTHOF EMG, Aitken CA, Siebers AG, van Kemenade FJ, et al
    Resilience of the Dutch HPV-based cervical screening programme during the COVID-19 pandemic.
    Public Health. 2024;227:42-48.
    

    >> Share

    
    

    
    Rev Med Virol

67. ASHOK G, Basu S, Priyamvada P, Anbarasu A, et al
    Coinfections in human papillomavirus associated cancers and prophylactic recommendations.
    Rev Med Virol. 2024;34:e2524.
    

    >> Share

    
    

    
    Sci Rep

68. TESFAYE E, Kumbi B, Mandefro B, Hemba Y, et al
    Prevalence of human papillomavirus infection and associated factors among women attending cervical cancer screening in setting of Addis Ababa, Ethiopia.
    Sci Rep. 2024;14:4053.
    

    >> Share

    
    

    
    Virulence

69. ZOU Q, Wu Y, Zhang S, Li S, et al
    Escherichia coli and HPV16 coinfection may contribute to the development of cervical cancer.
    Virulence. 2024;15:2319962.
    

    >> Share

    
    

    
    Womens Health Issues

70. PERKINS RB, Fuzzell L, Lake P, Brownstein NC, et al
    Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study.
    Womens Health Issues. 2024 Feb 20:S1049-3867(24)00001.
    

    >> Share

    
    

    
    World J Surg Oncol

71. WANG T, Li YY, Ma NN, Wang PA, et al
    A MRI radiomics-based model for prediction of pelvic lymph node metastasis in cervical cancer.
    World J Surg Oncol. 2024;22:55.
    

    >> Share

    
    

    
    Zhonghua Fu Chan Ke Za Zhi

72. LIU Q, Sun YX, Liu KJ, Li PQ, et al
    [Oncological outcomes of laparoscopic radical trachelectomy for early stage cervical cancer].
    Zhonghua Fu Chan Ke Za Zhi. 2024;59:135-142.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share